Author:
Mitchell Kyle G.,Antonoff Mara B.
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery
Reference6 articles.
1. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group;Pignon;J Clin Oncol,2008
2. Disparities in guideline-concordant treatment for pathologic N1 non-small cell lung cancer;Toubat;Ann Thorac Surg,2020
3. Toubat O.D.L., Ding K., et al: Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell cancer is unrecognized: A subgroup analysis of the JBR10 trial. Semin Thorac Cardiovasc Surg In press.
4. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer;Winton;N Engl J Med,2005
5. Osimertinib in resected EGFR-mutated non-small-cell lung cancer;Wu;N Engl J Med,2020